MedTrace Logo

The Effect of Motor Imagery Dosage on Motor Learning in Healthy Adults

NCT06299345 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2024-03-12

No results posted yet for this study

Summary

The goal of this clinical trial is to compare the effects of different durations of Motor Imagery (MI) practice and physical practice on motor performance enhancement in healthy adults. The main questions it aims to answer are:

* Does Motor Imagery (MI) practice improve motor performance?
* How do different doses of MI practice (low vs. high) compare to no MI practice in enhancing motor performance?

Participants:

* Be randomly assigned to one of three groups: no MI practice (control group), low dose MI practice (6 minutes per session), or high dose MI practice (12 minutes per session).
* Complete nine sessions over three weeks, practicing a timed mirror tracing task.
* Have their performance measured in each session by the time taken to complete the task and the number of errors made.

Compared the control group, low dose MI group, and high dose MI group to see if there are significant differences in motor performance enhancement, aiming to determine the effectiveness of MI and the optimal dose for practice.

Conditions

  • Healthy

Interventions

OTHER

Motor imagery training

MI for this study took the form of non-guided first-person mental practice. First-person imagery was explained to each participant where they imagined performing the target skill through their own eyes rather than if they were a bystander watching someone else do the task (third person).

OTHER

NO motor imagery training

The participants performed the physical task only. It is a mirror tracing game that requires participants to trace a star shape viewed through a mirror, going as fast as possible while staying within the lines.

Sponsors & Collaborators

  • Concordia University Wisconsin

    collaborator OTHER

  • Ahmed Mahmoud Kadry

    lead OTHER

Principal Investigators

  • Ahmed M Kadry, PhD · Associate Professor of Physical Therapy, Kafrelsheikh University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2022-04-20
Completion
2022-04-28

Countries

  • United States
  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06299345 on ClinicalTrials.gov